1. A randomised, double-blind, placebo controlled, dose ranging study of the safety and efficacy of tolterodine in patients with hyperreflexia;Abrams,1996
2. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder;Abrams;British Journal of Urology,1998
3. Efficacy and tolerability of tolterodine vs. oxybutynin and placebo in patients with detrusor instability (Abstract);Abrams;Journal of Urology,1997
4. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence;Anderson;Journal of Urology,1999
5. Central nervous system adverse events with anticholinergic medication for overactive bladder (Abstract 213);Anderson,2001